BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24874925)

  • 1. KLF2--a negative regulator of pre-B cell clonal expansion and B cell activation.
    Winkelmann R; Sandrock L; Kirberg J; Jäck HM; Schuh W
    PLoS One; 2014; 9(5):e97953. PubMed ID: 24874925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRF4 is a suppressor of c-Myc induced B cell leukemia.
    Pathak S; Ma S; Trinh L; Eudy J; Wagner KU; Joshi SS; Lu R
    PLoS One; 2011; 6(7):e22628. PubMed ID: 21818355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of KLF2 modulation on the transcriptional program and function of CD8 T cells.
    Preston GC; Feijoo-Carnero C; Schurch N; Cowling VH; Cantrell DA
    PLoS One; 2013; 8(10):e77537. PubMed ID: 24155966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome analysis in primary B lymphoid precursors following induction of the pre-B cell receptor.
    Schuh W; Meister S; Herrmann K; Bradl H; Jäck HM
    Mol Immunol; 2008 Jan; 45(2):362-75. PubMed ID: 17681603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel adaptor protein Swiprosin-1 enhances BCR signals and contributes to BCR-induced apoptosis.
    Avramidou A; Kroczek C; Lang C; Schuh W; Jäck HM; Mielenz D
    Cell Death Differ; 2007 Nov; 14(11):1936-47. PubMed ID: 17673920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcription factor KLF2 restrains CD4⁺ T follicular helper cell differentiation.
    Lee JY; Skon CN; Lee YJ; Oh S; Taylor JJ; Malhotra D; Jenkins MK; Rosenfeld MG; Hogquist KA; Jameson SC
    Immunity; 2015 Feb; 42(2):252-264. PubMed ID: 25692701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
    Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
    Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Krüppel-like factor 4 regulates B cell number and activation-induced B cell proliferation.
    Klaewsongkram J; Yang Y; Golech S; Katz J; Kaestner KH; Weng NP
    J Immunol; 2007 Oct; 179(7):4679-84. PubMed ID: 17878366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Myc-regulated transcriptional network controls B-cell fate in response to BCR triggering.
    Murn J; Mlinaric-Rascan I; Vaigot P; Alibert O; Frouin V; Gidrol X
    BMC Genomics; 2009 Jul; 10():323. PubMed ID: 19607732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatase Wip1 controls antigen-independent B-cell development in a p53-dependent manner.
    Yi W; Hu X; Chen Z; Liu L; Tian Y; Chen H; Cong YS; Yang F; Zhang L; Rudolph KL; Zhang Z; Zhao Y; Ju Z
    Blood; 2015 Jul; 126(5):620-8. PubMed ID: 26012568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cbl Ubiquitin Ligases Control B Cell Exit from the Germinal-Center Reaction.
    Li X; Gadzinsky A; Gong L; Tong H; Calderon V; Li Y; Kitamura D; Klein U; Langdon WY; Hou F; Zou YR; Gu H
    Immunity; 2018 Mar; 48(3):530-541.e6. PubMed ID: 29562201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor Zfx controls BCR-induced proliferation and survival of B lymphocytes.
    Arenzana TL; Smith-Raska MR; Reizis B
    Blood; 2009 Jun; 113(23):5857-67. PubMed ID: 19329779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRF4 Has a Unique Role in Early B Cell Development and Acts Prior to CD21 Expression to Control Marginal Zone B Cell Numbers.
    Ottens K; Satterthwaite AB
    Front Immunol; 2021; 12():779085. PubMed ID: 34880871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KLF4 suppresses transformation of pre-B cells by ABL oncogenes.
    Kharas MG; Yusuf I; Scarfone VM; Yang VW; Segre JA; Huettner CS; Fruman DA
    Blood; 2007 Jan; 109(2):747-55. PubMed ID: 16954505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kruppel-like factor 2 is required for trafficking but not quiescence in postactivated T cells.
    Takada K; Wang X; Hart GT; Odumade OA; Weinreich MA; Hogquist KA; Jameson SC
    J Immunol; 2011 Jan; 186(2):775-83. PubMed ID: 21160050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KLF2 (kruppel-like factor 2 [lung]) regulates osteoclastogenesis by modulating autophagy.
    Laha D; Deb M; Das H
    Autophagy; 2019 Dec; 15(12):2063-2075. PubMed ID: 30894058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
    Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
    Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Krüppel-like factor 2: a central regulator of B cell differentiation and plasma cell homing.
    Wittner J; Schuh W
    Front Immunol; 2023; 14():1172641. PubMed ID: 37251374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells.
    Grötsch B; Brachs S; Lang C; Luther J; Derer A; Schlötzer-Schrehardt U; Bozec A; Fillatreau S; Berberich I; Hobeika E; Reth M; Wagner EF; Schett G; Mielenz D; David JP
    J Exp Med; 2014 Oct; 211(11):2199-212. PubMed ID: 25288397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The KDM3A-KLF2-IRF4 axis maintains myeloma cell survival.
    Ohguchi H; Hideshima T; Bhasin MK; Gorgun GT; Santo L; Cea M; Samur MK; Mimura N; Suzuki R; Tai YT; Carrasco RD; Raje N; Richardson PG; Munshi NC; Harigae H; Sanda T; Sakai J; Anderson KC
    Nat Commun; 2016 Jan; 7():10258. PubMed ID: 26728187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.